Overview of POPDC2: A Potential Drug Target and Biomarker for Various Diseases

Target Name: POPDC2

NCBI ID: G64091

POPDC2

Overview of POPDC2: A Potential Drug Target and Biomarker for Various Diseases

POPDC2 (Pyruvate Kinase 2) is a gene that encodes a protein involved in the metabolism of pyruvate, a crucial carbon source for many organisms. The POPDC2 gene has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative disorders, and metabolic diseases. This article will provide an overview of POPDC2, its function, potential drug targets, and its potential as a biomarker.

Function of POPDC2

POPDC2 is a 21-kDa protein that is expressed in various tissues, including muscle, heart, liver, and brain. The protein has a molecular weight of 40 kDa and a pre-protein of 19 kDa. POPDC2 is involved in the metabolism of pyruvate, which is converted to acetyl-CoA and then to carbonyl-CoA, crucial for the citric acid cycle and the production of energy.

POPDC2 is a key enzyme in the citric acid cycle, and its activity is regulated by various factors, including pH, temperature, and substrate concentration. POPDC2 has been shown to play a role in the regulation of cellular metabolism, including cell growth , apoptosis, and inflammation.

Potential Drug Targets

POPDC2 has been identified as a potential drug target due to its involvement in various diseases. POPDC2 has been shown to be involved in the development and progression of cancer, including breast, ovarian, and prostate cancer. Additionally, POPDC2 has been linked to neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

POPDC2 has also been shown to be involved in the development of metabolic diseases, such as obesity, type 2 diabetes, and polycystic ovary syndrome (PCOS). The increased activity of POPDC2 has been observed in individuals with these diseases, and targeting POPDC2 may be a promising strategy for the development of new treatments for these diseases.

Biomarker Potential

POPDC2 has also been identified as a potential biomarker for various diseases. The expression of POPDC2 has been shown to be associated with the development of cancer, including breast, ovarian, and prostate cancer. Additionally, POPDC2 has been shown to be involved in the development of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

The increased expression of POPDC2 has also been observed in individuals with obesity, type 2 diabetes, and PCOS, providing a potential link between these diseases and POPDC2. Therefore, POPDC2 may be a useful biomarker for the diagnosis and assessment of progress in these diseases.

Conclusion

POPDC2 is a gene that encodes a protein involved in the metabolism of pyruvate, a crucial carbon source for many organisms. POPDC2 has been shown to play a role in the regulation of cellular metabolism and has been linked to the development and progression of various diseases, including cancer, neurodegenerative disorders, and metabolic diseases. Additionally, POPDC2 has been identified as a potential drug target and a biomarker for these diseases. Further research is needed to fully understand the role of POPDC2 in disease and to develop new treatments based on its potential as a drug target and biomarker.

Protein Name: Popeye Domain Containing 2

Functions: Important for the maintenance of cardiac function. Plays a regulatory function in heart rate dynamics mediated, at least in part, through cAMP-binding and, probably, by increasing cell surface expression of the potassium channel KCNK2 and enhancing current density

The "POPDC2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POPDC2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets